World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
27565
World Ranking
15527
National Ranking
7828

Overview

Youn H. Kim is affiliated with Stanford University in the United States and has a significant publication record in the field of medicine, particularly focusing on dermatology, pathology and forensic medicine, immunology, oncology, and epidemiology.

Their research emphasizes cutaneous lymphoproliferative disorders, lymphoma diagnosis and treatment, CAR-T cell therapy, T-cell and retrovirus studies, fungal infections, nail diseases, and chronic lymphocytic leukemia.

Recent papers authored or co-authored by Youn H. Kim include:

  • Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma, 2021, Nature Communications
  • T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC, 2021, Blood
  • NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020, 2020, Journal of the National Comprehensive Cancer Network
  • Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging, 2021, Frontiers in Immunology

Frequent co-authors of Youn H. Kim include:

  • Michael S. Khodadoust
  • Julia Scarisbrick
  • Pablo L. Ortiz-Romero
  • Pietro Quaglino
  • Joan Guitart

The scientist publishes regularly in several venues, with a focus on:

  • Blood
  • European Journal of Cancer
  • Journal of Clinical Oncology
  • Journal of the National Comprehensive Cancer Network
  • Blood Advances

The primary research topics explored include:

  • Cutaneous lymphoproliferative disorders research
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • T-cell and Retrovirus Studies
  • Fungal Infections and Studies
  • Nail Diseases and Treatments
  • Chronic Lymphocytic Leukemia Research

Best Publications

  • Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

    Elise Olsen;Eric Vonderheid;Nicola Pimpinelli;Rein Willemze

  • Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

    Elise A. Olsen;Youn H. Kim;Timothy M. Kuzel;Theresa R. Pacheco

  • Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome: Clinical Prognostic Factors and Risk for Disease Progression

    Youn H. Kim;Howard L. Liu;Serena Mraz-Gernhard;Anna Varghese

  • Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

    Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic

  • Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

    Sean J. Whittaker;Marie-France Demierre;Ellen J. Kim;Alain H. Rook

  • Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

    Elise Olsen;Madeleine Duvic;Arthur Frankel;Youn Kim

  • TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

    Youn H. Kim;Rein Willemze;Nicola Pimpinelli;Sean Whittaker

  • Phase 2 and 3 Clinical Trial of Oral Bexarotene (Targretin Capsules) for the Treatment of Refractory or Persistent Early-Stage Cutaneous T-Cell Lymphoma

    Madeleine Duvic;Ann G. Martin;Youn Kim;Elise Olsen

  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    H Miles Prince;H Miles Prince;Youn H Kim;Steven M Horwitz;Reinhard Dummer

  • European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

    Nancy J. Senff;Evert M. Noordijk;Youn H. Kim;Martine Bagot

  • In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

    Joshua D. Brody;Weiyun Z. Ai;Debra K. Czerwinski;James A. Torchia

  • EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

    Werner Kempf;Katrin Pfaltz;Maarten H. Vermeer;Antonio Cozzio

  • Non-Hodgkin's Lymphomas

    Andrew D. Zelenetz;Ranjana H. Advani;John C. Byrd;Myron S. Czuczman

  • Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

    Julia J. Scarisbrick;H. Miles Prince;Maarten H. Vermeer;Pietro Quaglino

  • NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.

    Zelenetz Ad;Abramson Js;Advani Rh;Andreadis Cb

  • Cd30+ cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma ☆

    Howard L. Liu;Richard T. Hoppe;Sabine Kohler;Jeff D. Harvell

  • Clinical Stage IA (Limited Patch and Plaque) Mycosis Fungoides: A Long-term Outcome Analysis

    Youn H. Kim;Reini A. Jensen;Garrett L. Watanabe;Anna Varghese

  • Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

    Youn H. Kim;Mahkam Tavallaee;Uma Sundram;Katrin A. Salva

  • Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2

    Alexander Ungewickell;Aparna Bhaduri;Eon Rios;Jason Reuter

  • Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.

    Madeleine Duvic;Lauren C. Pinter-Brown;Francine M. Foss;Lubomir Sokol

Frequent Co-Authors

Richard T. Hoppe
Richard T. Hoppe Stanford University
Madeleine Duvic
Madeleine Duvic The University of Texas MD Anderson Cancer Center
Sean Whittaker
Sean Whittaker King's College London
Martine Bagot
Martine Bagot Université Paris Cité
Ranjana H. Advani
Ranjana H. Advani Stanford University
Reinhard Dummer
Reinhard Dummer University of Zurich
Gary S. Wood
Gary S. Wood University of Wisconsin–Madison
Rein Willemze
Rein Willemze Leiden University Medical Center
Pier Luigi Zinzani
Pier Luigi Zinzani University of Bologna
Timothy M. Kuzel
Timothy M. Kuzel Rush University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical education opens doors to a range of online degrees and evolving career paths in healthcare. For those interested in healthcare leadership or administration, check out the top cahme-accredited mha programs. These programs are designed for students aspiring to management roles in hospitals or healthcare organizations and often offer flexible study options.

Nursing professionals looking to elevate their credentials without extensive clinical requirements can explore online rn-bsn programs without clinicals. These programs are tailored for registered nurses seeking to earn their BSN in a convenient online format.

For advanced practice nurses, quick advancement is possible through the shortest msn to dnp program options. These programs help you reach the highest level of clinical nursing expertise in less time.

Alternatively, if you're concerned about hands-on requirements, a dnp program without clinical hours could be a practical solution. These programs can help working professionals advance their doctoral training without additional clinical placements.

Best Scientists Citing Youn H. Kim

Trending Scientists

Recently Published Articles